Submit an Abstract
- Roundtable proposal submissions January 18 – April 8, 2022 – CLOSED
- Poster proposal submissions January 18 – April 12, 2022 – CLOSED
- Accepted parallel session abstract submissions April 14 – May 18, 2022
Invited Speakers for Accepted Parallel Sessions
You will need the Session ID, provided by the session organizer, to submit your abstract. If you do not know your Session ID, please reach out to your organizer directly.
An email confirming your submission will be sent to the email address you provided. If you do not receive the email confirmation or encounter difficulties with this system, please contact the ASA Meetings Department at firstname.lastname@example.org or (703) 684-1221.
* A Note to Speakers from FDA Divisions
Please be sure to list “FDA” or “Food and Drug Administration” as your affiliation and select your division within the FDA from the drop-down menu when submitting your abstract. All speakers listing “FDA” as their affiliation will be included in our request to the FDA for speakers to present at the workshop.
Please keep in mind that parallel sessions are only 75 minutes in length (plenary sessions are 90 minutes). There should be no more than three speakers for a parallel session–two speakers plus a discussant or two speakers plus a small panel.
To encourage a diverse set of presenters, the following restrictions will apply. Each individual may do any or all of the following activities labeled (a), (b), or (c):
(a) Parallel sessions
1. Organize up to two sessions or have any other active role in up to two parallel sessions with the following restrictions* (see #2–#5)
2. Chair† only one session, which can be a session they organized
3. Give a presentation in only one session, but not in a session for which they are serving as chair
4. Serve as a panelist in only one session, which could be in the same session in which they present
5. Serve as a discussant in only one session, but not in the same session in which they present or chair
(b) Roundtable leader
Lead one roundtable discussion
(c) Short course teacher Teach one short course
Under (a), a person cannot hold multiple roles within one session. For example, one person cannot serve as both the chair and a speaker in the same session. However, the session’s organizer may serve as a presenter, discussant, panelist, or chair in that session, but not more than one of these roles.
For example, it is possible for the same person to do at most the following: organize one session, be the chair of the session he/she organizes and be the presenter in another session, lead one roundtable, and teach one short course.
†The chair is responsible for keeping time for each presentation, introducing the speakers, and starting and ending the session on time.
Plenary session: Being a speaker or panelist of a plenary session is considered being invited, and therefore exempted from the rules above. It can be done in addition to any of the roles in (a), (b), and (c).
Diversity: To ensure diversity of speakers’ affiliations, every session must have at least one presenter from industry and one from the FDA. A third speaker from academia is ideal, but not required for all sessions. If two or more speakers/panelists are from industry, they must be from different companies.
* Because FDA participants are in high demand, these restrictions may be suspended for FDA participants to ensure FDA presence at the workshop with approval from the Workshop Co-Chairs.